This report includes the retinitis pigmentosa pipeline analysis as of November 2017, to estimate and analyze the emerging therapies and their progress status in different phases of development. The report also contains competitive analysis and extensive information on monotherapies, targets and mechanism of action, and drug origin with relevance to retinitis pigmentosa.
Retinitis Pigmentosa Therapeutics Pipeline Analysis
By Molecule Type
By Route of Administration